Studies of the Toxicological Potential of Capsinoids, XIII: Inhibitory Effects of Capsaicin and Capsinoids on Cytochrome P450 3A4 in Human Liver Microsomes

被引:22
|
作者
Takanohashi, Toshiyuki [1 ]
Isaka, Mitsuyoshi
Ubukata, Kazuyuki
Mihara, Ryuichi
Bernard, Bruce K. [2 ]
机构
[1] Ajinomoto Co Inc, Pharmaceut Co, Pharmaceut Res Labs, Nonclin Dev Res Dept,Kawasaki Ku, Kanagawa, Japan
[2] SRA Int Inc, Cambridge, MD USA
关键词
capsaicin; capsinoids; human liver microsomes; cytochrome P450 3A4; CH-19 SWEET EXTRACT; COMMERCIAL-GRADE DIHYDROCAPSIATE; SINGLE-DOSE TOXICITY; IN-VITRO; DRUG-INTERACTIONS; 13-WEEK TOXICITY; CAPSICUM-ANNUUM; RATS; METABOLISM; PEPPER;
D O I
10.1177/1091581809360282
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This study evaluated potential effects of a number of capsinoids (ie, capsiate, dihydrocapsiate, nordihydrocapsiate) and a single capsaicinoid (ie, capsaicin) on liver microsomal cytochrome P450 3A4-mediated midazolam I'-hydroxylase activity. Where possible, an inhibition curve was prepared; the concentration at which enzyme activity dropped to 50% was calculated. Capsaicin clearly inhibited cytochrome P450 3A4 activity, losing 50% of the activity at 21.5 mu mol/L. No enzyme inhibition was observed in the presence of capsiate, dihydrocapsiate, or nordihydrocapsiate (<100 mu mol/L). Preincubation increased the capsaicin inhibitory activity against cytochrome P450 3A4 in a time-dependent manner. Enzyme activity was slightly reduced by capsiate, dihydrocapsiate, and nordihydrocapsiate to the same level as that attained with tolbutamide, the negative control compound. Capsaicin was shown to inhibit cytochrome P450 3A4, probably through a mechanism-based inhibition. In contrast, capsiate, dihydrocapsiate, and nordihydrocapsiate did not inhibit cytochrome P450 3A4 activity and were unlikely to be mechanism-based inhibitors of CYP3A4.
引用
收藏
页码:22S / 26S
页数:5
相关论文
共 50 条
  • [41] Inhibitory effects of cuminaldehyde on human liver cytochrome P450 enzymes
    Alharbi, Naif Fahad M.
    Ahad, Abdul
    Bin Jardan, Yousef A.
    Al-Jenoobi, Fahad I.
    JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2024, 36 (10)
  • [42] Inhibitory Effects of Curcumenol on Human Liver Cytochrome P450 Enzymes
    Sun, Dong-Xue
    Fang, Zhong-Ze
    Zhang, Yan-Yan
    Cao, Yun-Feng
    Yang, Ling
    Yin, Jun
    PHYTOTHERAPY RESEARCH, 2010, 24 (08) : 1213 - 1216
  • [43] Sertraline and cytochrome P450 3A4 in dysthymia
    Dunn, E
    Helpard, B
    Steiner, M
    BIOLOGICAL PSYCHIATRY, 1997, 41 : 116 - 116
  • [44] Molecular modeling of cytochrome P450 3A4
    Grazyna D. Szklarz
    James R. Halpert
    Journal of Computer-Aided Molecular Design, 1997, 11 : 265 - 272
  • [45] Inhibitory effects of curculigoside on human liver cytochrome P450 enzymes
    Lang, Jixiao
    Li, Wei
    Zhao, Jingming
    Wang, Kaiyou
    Chen, Dexi
    XENOBIOTICA, 2017, 47 (10) : 849 - 855
  • [46] Inhibitory effects of sanguinarine on human liver cytochrome P450 enzymes
    Qi, Xiao-Yi
    Liang, Si-Cheng
    Ge, Guang-Bo
    Liu, Yong
    Dong, Pei-Pei
    Zhang, Jiang-Wei
    Wang, Ao-Xue
    Hou, Jie
    Zhu, Liang-Liang
    Yang, Ling
    Tu, Cai-Xia
    FOOD AND CHEMICAL TOXICOLOGY, 2013, 56 : 392 - 397
  • [47] Molecular simulations of cytochrome P450 3A4
    Czapla, Luke
    Amaro, Rommie E.
    Kontoyianni, Maria
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 243
  • [48] Inhibitory effects of cornuside on human liver cytochrome P450 enzymes
    Yang, Yanmo
    Zhang, Ke
    Zhou, Mi
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2025,
  • [49] Biotransformation of zafirlukast by cytochrome P450 3A4
    Skordos, KW
    Yost, GS
    DRUG METABOLISM REVIEWS, 2003, 35 : 49 - 49
  • [50] Inhibitory effect of salvianolate on human cytochrome P450 3A4 in vitro involving a noncompetitive manner
    Qin, Chong-Zhen
    Ren, Xian
    Zhou, Hong-Hao
    Mao, Xiao-Yuan
    Liu, Zhao-Qian
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2015, 8 (09): : 15549 - 15555